0.5344
0.11%
-0.000601
GlucoTrack Inc stock is currently priced at $0.5344, with a 24-hour trading volume of 93,550.
It has seen a -0.11% decreased in the last 24 hours and a +63.38% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.5465 pivot point. If it approaches the $0.5029 support level, significant changes may occur.
Previous Close:
$0.535
Open:
$0.5618
24h Volume:
93,550
Market Cap:
$14.30M
Revenue:
-
Net Income/Loss:
$-7.10M
P/E Ratio:
-1.67
EPS:
-0.32
Net Cash Flow:
$-6.56M
1W Performance:
+11.57%
1M Performance:
+63.38%
6M Performance:
+205.37%
1Y Performance:
+44.43%
GlucoTrack Inc Stock (GCTK) Company Profile
Name
GlucoTrack Inc
Sector
Industry
Phone
972 8 675 7878
Address
8 Ariel Sharon Street, PO Box 6037607, Or Yehuda
GlucoTrack Inc Stock (GCTK) Latest News
GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT
GlobeNewswire Inc.
GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING
GlobeNewswire Inc.
GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR
GlobeNewswire Inc.
GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY
GlobeNewswire Inc.
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS
GlobeNewswire Inc.
GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR
GlobeNewswire Inc.
GlucoTrack Inc Stock (GCTK) Financials Data
GlucoTrack Inc (GCTK) Net Income 2024
GCTK net income (TTM) was -$7.10 million for the quarter ending December 31, 2023, a -60.02% decrease year-over-year.
GlucoTrack Inc (GCTK) Cash Flow 2024
GCTK recorded a free cash flow (TTM) of -$6.56 million for the quarter ending December 31, 2023, a -75.82% decrease year-over-year.
GlucoTrack Inc (GCTK) Earnings per Share 2024
GCTK earnings per share (TTM) was -$0.37 for the quarter ending December 31, 2023, a -27.59% decline year-over-year.
About GlucoTrack Inc
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
Cap:
|
Volume (24h):